Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial

Artículo original

Año: 2024

Hidalgo-Tenorio, C; Sequera, S; Vivancos, MJ; Vinuesa, D; Collado, A; de los Santos, I; Sorni, P; Cabello-Clotet, N; Montero, M; Font, CR; Terron, A; Galindo, MJ; Martinez, O; Ryan, P; Omar-Mohamed, M; Albendín-Iglesias, H; Javier, R; López-Ruz, MA; Romero, A; Garcia-Vallecillos, C

Título: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

• Q1